Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH)

121 filings reported holding DNTH - Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value as of Q2 2025.
Dianthus Therapeutics, Inc. /DE/ - Common Stock, $0.001 par value (DNTH) has 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 39.1M shares of 43.7M outstanding shares and own 89.56% of the company stock.
Largest 10 shareholders include FMR LLC (4.54M shares), Vestal Point Capital, LP (3.2M shares), RA CAPITAL MANAGEMENT, L.P. (2.87M shares), Fairmount Funds Management LLC (2.71M shares), Bain Capital Life Sciences Investors, LLC (2.48M shares), Octagon Capital Advisors LP (2.34M shares), Deep Track Capital, LP (2.23M shares), Avidity Partners Management LP (1.74M shares), TCG Crossover Management, LLC (1.5M shares), and VANGUARD GROUP INC (1.45M shares).
This table shows the top 101 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.